Today

Agents

Chat

Arena

Discover

More

App

Hepion Pharmaceuticals names James Liddy to board - HEPA News | Rallies

Hepion Pharmaceuticals names James Liddy to board

HEPA•2026-08-20

Board appointment effective Aug. 19, 2026

Hepion Pharmaceuticals appointed James Liddy to its board, effective Aug. 19, 2026.
The filing disclosed no selection arrangements tied to Liddy.
No reportable related-party transactions involving Liddy were identified.

Related News

Ondas director Richard M. Cohen disposes of 7,500 common shares worth $67,177.50

ONDS•2026-08-20

Security National Bank names Mike Husmann IT director, officer

SNFCA•2026-08-20

US firm Powerus wins $22.3 million contract to protect Middle East energy infrastructure from drones

Sources

S

Hepion Pharmaceuticals names James Liddy to board

Sec

PUSA

•

2026-08-20

RE/MAX holders elect cash-stock mix in Real Brokerage takeover, closing seen Aug. 24

RMAX•2026-08-20

Arch Capital CFO and Treasurer Francois Morin sells 11,010 common shares for $1.09 million

ACGL•2026-08-20